Ligand Pharmaceuticals Incorporated (LGND)
NASDAQ: LGND · Real-Time Price · USD
114.15
-1.54 (-1.33%)
Jun 27, 2025, 4:00 PM - Market closed
Ligand Pharmaceuticals Employees
Ligand Pharmaceuticals had 68 employees as of December 31, 2024. The number of employees increased by 10 or 17.24% compared to the previous year.
Employees
68
Change (1Y)
10
Growth (1Y)
17.24%
Revenue / Employee
$2,668,941
Profits / Employee
-$1,950,324
Market Cap
2.20B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
LGND News
- 3 days ago - Ligand Pharmaceuticals: Attractive Royalty Model Powers Forward - Seeking Alpha
- 17 days ago - Ligand Announces 2025 Investor Day in New York City - GlobeNewsWire
- 6 weeks ago - Ligand to Ring the Nasdaq Opening Bell on May 19, 2025 - GlobeNewsWire
- 7 weeks ago - Ligand Pharmaceuticals Incorporated (LGND) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - Ligand Reports First Quarter 2025 Financial Results - GlobeNewsWire
- 2 months ago - Ligand to Participate in May Investor Conferences - GlobeNewsWire
- 2 months ago - Ligand to Report First Quarter 2025 Financial Results on May 8, 2025 - GlobeNewsWire
- 2 months ago - Ligand Subsidiary Pelthos Therapeutics to Combine with Channel Therapeutics - GlobeNewsWire